METOPROLOL TARTRATE USP (PROCESS III)

PARICALCITOL USP (NON-STERILE DRUG SUBSTANCE)

AMLODIPINE BESYLATE (NON-STERILE DRUG SUBSTANCE)

TROVOPROST (TOS-00)

POLAPREZINC

CHONDROITIN SULFATE SODIUM

FLUOCINONIDE (NEW PROCESS)

DRUG SUBSTANCE MANUFACTURING AT NOVARTIS BPO HUNINGUE

TRIAMCINOLONE ACETONIDE USP

CINACALCET HYDROCHLORIDE

SIMVASTATIN USP

SEPINEO� P 600

MERCAPTOPURINE USP

2,3-DIDEHYDROGEN-2,3-DIDEOXY INOSINE SODIUM FOR DIDANOSINE INTERMEDIATE (D4I SODIUM)

CONTAINER FOR PACKAGING HUMAN DRUGS

METHOTREXATE USP

METOCLOPRAMIDE HYDROCHLORIDE USP

IRINOTICAN HYDROCHLORIDE

709319 NATURAL ORANGE FLAVOR WONF

GEMCITABINE HYDROCHLORIDE USP

DOCETAXEL ANHYDROUS

FINASTERIDE USP

ZIDOVUDINE USP

LAMIVUDINE USP

STAVUDINE USP

NEVIRAPINE USP

SPIKE PORT AND INJECTION PORT

CHOLESTEROL-3,4-(13)C(2), FOR PHASE I CLINICAL STUDIES

Xenon Xe-133

Xe

Pentagalloyl-D-glucose

Carbonothioic chloride fluoride

CClFS

Simeconazole

C14H20FN3OSi